Xbrane Biopharma AB's total assets for Q1 2026 were kr670.76M, a decrease of -0.13% from the previous quarter. SE:XBRANE total liabilities were kr120.60M for the fiscal quarter, a 8.68% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.